2021

1. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can

   Frontiers in Immunology, Vol. 12

2. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection

   Journal of Personalized Medicine, Vol. 11, Núm. 7

3. HGF, IL-1α, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients

   Journal of Clinical Medicine, Vol. 10, Núm. 9

4. Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles

   Journal of Clinical Medicine, Vol. 10, Núm. 22